Therapeutic Advances in Ophthalmology: Corneal endothelial cell dysfunction: etiologies and management

7 December 2018
Source: Therapeutic Advances in Ophthalmology

Abstract   A transparent cornea is essential for the formation of a clear image on the retina. The human cornea is arranged into well-organized layers, and each layer plays a significant role in maintaining the transparency and viability of the tissue. The endothelium has both barrier and pump functions, which are important for the maintenance of corneal clarity. Many etiologies,

Read more Therapeutic Advances in Ophthalmology: Corneal endothelial cell dysfunction: etiologies and management

Retina UK: Gene therapy for RPE65 gene approved for use in EU

23 November 2018
Source: Retina UK

The gene therapy Luxturna has won European regulatory approval for the treatment of Inherited retinal dystrophy caused by mutations in the RPE65 gene. This milestone decision was made by the European Medicines Agency (EMA) on Thursday, 22 November. Luxturna is the first and only gene therapy available in Europe to treat inherited retinal disease. It had already been approved for

Read more Retina UK: Gene therapy for RPE65 gene approved for use in EU

NIHR: Eye disease patients have more opportunity than ever to take part in NHS research studies

21 November 2018
Source: NIHR

• 76 per cent of hospitals in England now offer patients the opportunity to take part in eye disease studies • 15,500 patients per year offered innovative treatments for diseases such as age-related macular degeneration • Ophthalmology community ‘punching above its weight’ in world of research A new paper published today highlights how some 76 per cent of hospitals in

Read more NIHR: Eye disease patients have more opportunity than ever to take part in NHS research studies

Macular Society: Diabetes medication may protect against AMD

14 November 2018
Source: Macular Society

Researchers from Taiwan have shown that people with type 2 diabetes who took a common diabetes medication, had a significantly lower rate of age-related macular degeneration (AMD). The study suggests that the anti-inflammatory and anti-oxidative effects of the drug metformin can protect against AMD, while it controls diabetes. The research was presented at AAO 2018, the 122nd Annual Meeting of

Read more Macular Society: Diabetes medication may protect against AMD

University of Nottingham: Eye discovery to pave way for more successful corneal transplants

6 October 2018

A team of eye specialists at the University of Nottingham has made another novel discovery  that could help to improve the success of corneal transplants for patients whose sight has been affected by disease. The research, published in the October edition of the American Journal of Ophthalmology, has shed light on a characteristic of a thin membrane called the Descemets

Read more University of Nottingham: Eye discovery to pave way for more successful corneal transplants

National Eye Health Week 2018: Research funding will use iPads to identify the best method to manage nystagmus

28 September 2018
Source: Fight for Sight and Nystagmus Network

Fight for Sight and The Nystagmus Network have announced funding for three exciting nystagmus research projects at the Nystagmus Network Conference, which is taking place today during National Eye Health Week 2018. In total £30,000 in funding will be used for projects bringing benefits to children and adults living with the condition, which is characterised by involuntary and repetitive movements

Read more National Eye Health Week 2018: Research funding will use iPads to identify the best method to manage nystagmus

Macular Society, National Eye Health Week – Could our immune system be causing AMD?

28 September 2018
Source: Macular Society

Imagine not being able to read the newspaper, or enjoy the autumn flowers in the garden? Imagine seeing fuzzy images and blurred lines? This is what people living with Macular Degeneration, or AMD, deal with every day. In the UK, around 600,000 people are living with AMD and around 70,000 new cases are diagnosed every year: that’s nearly 200 every

Read more Macular Society, National Eye Health Week – Could our immune system be causing AMD?

Blind Veterans UK, the Macular Society, Scottish War Blinded and Fight for Sight team up to fight for sight and tackle a leading cause of blindness

27 September 2018
Source: Action Against AMD

Fight for Sight is pleased to announce that it has entered into a new partnership to find a treatment for one of the world’s leading causes of blindness. Working with Blind Veterans UK, the Macular Society and Scottish War Blinded, the charities have launched a new collaboration to transform the funding of research to address age-related macular degeneration (AMD). The

Read more Blind Veterans UK, the Macular Society, Scottish War Blinded and Fight for Sight team up to fight for sight and tackle a leading cause of blindness

Papers for the 1st meeting of the Vision UK Research, Cures and Treatments Panel 17/09/18

17 September 2018
Source: Vision UK

Papers for the 1st meeting of the Vision UK Research, Cures and Treatments Panel 17/09/18  

Read more Papers for the 1st meeting of the Vision UK Research, Cures and Treatments Panel 17/09/18
Attach 1 - Agenda For Vision UK RC&T Panel 170918
Attach 1 - Agenda For Vision UK RC&T Panel 170918
Download docx 49 KB
Attach 2 - ToR For Vision UK RC&T Panel V210818
Attach 2 - ToR For Vision UK RC&T Panel V210818
Download doc 0.3 MB

Vision UK Announce the chairs for two of their strategic transformational panels

28 August 2018
Source: Vision UK

Vision UK are delighted to announce that the we have recruited joint chairs for both the Vision UK Research, Cures and Treatments panel and the Vision UK Services, Support and Care panel. Vision UK’s mission is to improve lives by raising the priority given to eye health and sight loss. We will involve private, public and voluntary organisations to: improve

Read more Vision UK Announce the chairs for two of their strategic transformational panels